PAMELA EDWARDS: Open Payments
NPI 1467197301 · JACKSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,084 in 288 payments from 20 companies in 2025. Trend: 2023 $4,872 · 2024 $4,766 · 2025 $5,084
Food & beverage: $4,861Education: $223
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 56 | $722 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 28 | $664 |
| E.R. Squibb & Sons, L.L.C. | 25 | $645 |
| ABBVIE INC. | 18 | $363 |
| Vanda Pharmaceuticals Inc. | 18 | $360 |
| Lundbeck LLC | 26 | $338 |
| Neurocrine BioSciences, Inc. | 27 | $321 |
| Alkermes, Inc. | 16 | $320 |
| Teva Pharmaceuticals USA, Inc. | 9 | $300 |
| Janssen Pharmaceuticals, Inc | 12 | $244 |
Products named: REXULTI, CAPLYTA, COBENFY, VRAYLAR, INGREZZA, HETLIOZ, ARISTADA, LOREEV XR.
Industry payments across NC — which companies pay providers there.
